Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H20N4O.ClH |
| Molecular Weight | 332.828 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(CN1C2=CC=CC=C2NC3=NC=CC=C3C1=O)N(C)C
InChI
InChIKey=DNZVNKSQOUOBOY-UHFFFAOYSA-N
InChI=1S/C17H20N4O.ClH/c1-12(20(2)3)11-21-15-9-5-4-8-14(15)19-16-13(17(21)22)7-6-10-18-16;/h4-10,12H,11H2,1-3H3,(H,18,19);1H
| Molecular Formula | C17H20N4O |
| Molecular Weight | 296.3669 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Method development for a pyridobenzodiazepine library with multiple diversification points. | 2008-02-12 |
|
| Recent advances in the solid-phase combinatorial synthetic strategies for the benzodiazepine based privileged structures. | 2006-01 |
|
| Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia. | 2001-07 |
|
| Effects of long-term treatment of rats with antidepressants on adrenergic-receptor sensitivity in cerebral cortex: Structure activity study. | 1983 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:24:32 GMT 2025
by
admin
on
Mon Mar 31 22:24:32 GMT 2025
|
| Record UNII |
Z5MO8L6XHR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Z5MO8L6XHR
Created by
admin on Mon Mar 31 22:24:32 GMT 2025 , Edited by admin on Mon Mar 31 22:24:32 GMT 2025
|
PRIMARY | |||
|
m9216
Created by
admin on Mon Mar 31 22:24:32 GMT 2025 , Edited by admin on Mon Mar 31 22:24:32 GMT 2025
|
PRIMARY | Merck Index | ||
|
14559-79-6
Created by
admin on Mon Mar 31 22:24:32 GMT 2025 , Edited by admin on Mon Mar 31 22:24:32 GMT 2025
|
PRIMARY | |||
|
3082068
Created by
admin on Mon Mar 31 22:24:32 GMT 2025 , Edited by admin on Mon Mar 31 22:24:32 GMT 2025
|
PRIMARY | |||
|
DTXSID30932648
Created by
admin on Mon Mar 31 22:24:32 GMT 2025 , Edited by admin on Mon Mar 31 22:24:32 GMT 2025
|
PRIMARY | |||
|
238-603-8
Created by
admin on Mon Mar 31 22:24:32 GMT 2025 , Edited by admin on Mon Mar 31 22:24:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |